ABCL AbCellera Biologics Inc.

NASDAQ
$11.12

AbCellera Biologics Inc. (ABCL) Earnings News

Earnings press releases, previews and reviews for AbCellera Biologics Inc. (ABCL), newest first. Our most recent is review: AbCellera Tops Estimates, but ABCL635's Breakout Phase 2 Data and a $900 Million War Chest Are the Real Story.